Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Blue Owl close to $2.7bn stake sale from Dyal Capital Partners IV
Blue Owl close to $2.7bn stake sale from Dyal Capital Partners IV Blue Owl Capital is close to completing a $2.7bn secondary transaction on its Dyal Capital Partners IV fund, in a move designed to return cash to investors and lift performance metrics, Bloomberg...
Blackstone and Ares provide $3.6bn debt package for Warburg Pincus’ Park Place buyout
Blackstone and Ares provide $3.6bn debt package for Warburg Pincus’ Park Place buyout Blackstone and Ares Management are providing $3.6bn in private credit to finance Warburg Pincus’ acquisition of Park Place Technologies, one of the largest private debt packages seen...
EQT, Carlyle, and HongShan advance in bidding for Starbucks’ China operations
EQT, Carlyle, and HongShan advance in bidding for Starbucks’ China operations Carlyle Group, EQT, HongShan Capital, Boyu Capital, and Primavera Capital have emerged as final bidders for a controlling stake in Starbucks’ China operations, according to sources cited by...




